治疗前能谱CT联合CT灌注可预测急性缺血性卒中溶栓后出血转化
出血转化组梗死核心区CBF较低,缺血半暗带区碘浓度及有效原子序数较低、能谱曲线斜率较大。多因素分析显示梗死核心区CBF和缺血半暗带区碘浓度是出血转化的独立预测因子,联合临床、能谱和CTP参数的模型预测效能有所提高。
要点
- 缺血半暗带区碘浓度是溶栓后出血转化的独立预测因子。
- 梗死核心区CBF降低也与出血转化风险独立相关。
- 联合临床、能谱CT和CTP参数的多因素模型可提高预测效能。
关键影像表现/征象
- 出血转化组SITS评分更高(p=0.023),灌注病灶体积更大(p=0.005),缺血半暗带体积更大(p=0.003)。
- 出血转化组梗死核心区平均通过时间更长(p=0.012),缺血半暗带区达峰时间更长(p=0.015)。
- 出血转化组梗死核心区CBF更低(p=0.019),缺血半暗带区碘浓度更低(p=0.017),有效原子序数更低(p=0.024)。
- 出血转化组缺血半暗带区能谱曲线斜率大于非出血转化组(p=0.023)。
诊断标准与关键数值
- 梗死核心区CBF为出血转化的独立预测因子(OR=0.779,95%CI:0.609-0.996,p=0.046)。
- 缺血半暗带区碘浓度为出血转化的独立预测因子(OR=0.343,95%CI:0.131-0.901,p=0.030)。
- 联合临床、能谱和CTP参数的模型准确性优于仅含临床+能谱参数或临床+CTP参数的模型,但Delong检验差异无统计学意义(两者p值均>0.05)。
临床应用与阅片要点
- 治疗前能谱CTA可同时获得血管成像和碘浓度等定量参数,阅片时可关注缺血半暗带区碘浓度。
- 结合CTP参数(梗死核心区CBF、缺血半暗带区TTP等)综合评估出血转化风险。
- 注意本研究样本量小,模型预测效能需外部验证,不宜单独用于临床决策。
局限性
- 联合模型与其他模型预测效能差异无统计学意义(Delong检验p>0.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the value of pre-treatment spectral CT angiography (CTA) in predicting hemorrhagic transformation (HT) after intravenous thrombolysis (IVT) treatment in acute ischemic stroke (AIS) patients.
MATERIALS AND METHODS: AIS patients who underwent IVT with recombinant tissue plasminogen activator and pre-treatment head and neck spectral CTA and head CT perfusion (CTP) from January 2018 to June 2020 were reviewed retrospectively. Finally, 20 patients were included in the HT group and 22 age-matched patients were included in the non-HT group. Spectral and CTP parameters of the region of interest on pre-treatment CTA axial raw images and CTP images, including the infarct core (IC) and ischemic penumbral (IP) regions, were recorded. The differences in clinical variables, CTP, collateral scores and spectral parameters between the two groups were analyzed. Three multivariate logistic regression models were then developed, where model 1 included clinical and spectral parameters, model 2 included clinical and CTP parameters and a combined model included clinical, CTP, and spectral parameters. Receiver operating characteristic analysis was used to evaluate the performance of the multivariate model.
RESULTS: Patients with HT had higher Safe Implementation of Treatments in Stroke (SITS) score (p = 0.023), the volume of perfusion lesions (p = 0.005), the volume of IP (p = 0.003), the mean transit time (MIT) in the IC area (p = 0.012), as well as the TTP in IP area (p = 0.015) compared with patients without HT. The HT group showed significantly lower CBF in the IC area (p = 0.019), iodine concentration (p = 0.017) and the effective atomic number (p = 0.024) in the IP area than non-HT group. And the slope of the spectral curve of the HT group in the IP region was larger than that of the non-HT group (p = 0.023). Gender, age, SITS score, the volume of entire perfusion lesion, CBF and MIT in the IC area, TTP in the IP area, as well as iodine concentration in the IP area were included in the final multivariate model for predicting HT. And CBF in the IC area (OR = 0.779, 95 % CI:0.609-0.996, p = 0.046) as well as the iodine concentration of IP area (OR = 0.343, 95 % CI: 0.131-0.901, p = 0.030) were proved to be independent predictors for HT. The combined model including clinical, spectral, and CTP parameters, showed improved accuracy compared to the other two models, while the Delong test did not suggest a statistically significant difference (both p values > 0.05).
CONCLUSIONS: The iodine concentration of IP area derived from pre-treatment spectral CTA was an independent predictor of HT after IVT treatment for AIS patients. Moreover, multivariate models combined with clinical, spectral, and CTP parameters may be able to predict HT.
引用
- Han, Huang, Yao, et al. Pre-treatment spectral CT combined with CT perfusion can predict hemorrhagic transformation after thrombolysis in patients with acute ischemic stroke. Eur J Radiol. 2022. PMID: 36179464. doi:10.1016/j.ejrad.2022.110543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。